Last updated on July 27, 2026 · Originally published November 10, 2022
As the discovery of more terpenes and their effects continues to blossom, one of the most studied is proving to be alpha-pinene. With applications from fragrances to inflammation relief, a particularly interesting potential benefit may come in the field of cognitive function — specifically through its relationship with memory. The story, though, has taken some unexpected turns in recent years.
Neurological effects of pinene
In one 2017 study that demonstrated the possible effect of alpha-pinene on memory, researchers set out to test for a natural therapy for Alzheimer’s disease. The authors indicate that Alzheimer’s stems from various forms of neurological distress in the regions of the brain responsible for memories. While some treatment does exist, the benefits are usually mild and short-term, and there are multiple undesirable side effects. When testing pinene on mice, they discovered that animals who received doses of the terpene were able to solve mazes significantly faster than those who did not. The researchers credit this to a molecular response in the brain that helps bypass certain neurodegenerative processes.
More recent animal research has added a new layer to that picture. A 2023 study published in Frontiers in Molecular Neuroscience found that alpha-pinene reduced memory impairment in rats exposed to kainic acid — a compound used to model seizure-related brain damage — by restoring a key neuroprotective signalling pathway involving brain-derived neurotrophic factor (BDNF), its receptor TrkB, and a transcription factor called CREB. BDNF is a protein that supports the survival of existing neurons and encourages the growth of new ones; its suppression is associated with a range of neurodegenerative conditions. The fact that alpha-pinene appeared to restore these levels in hippocampal tissue — the brain region central to memory formation — adds a mechanistic dimension to what earlier maze studies could only observe behaviourally.
These are preclinical findings, conducted in rodents, and translating animal neuroscience to human cognition is never straightforward. But they do suggest alpha-pinene isn’t simply a passive aromatic molecule. It is worth noting that alpha- and beta-pinene are distinct compounds with different properties, a distinction we cover in our look at the pinene isomers.
Pinene and short-term memory
Pinene demonstrates potential for improving short-term memory through its inhibition of acetylcholinesterase — the enzyme responsible for breaking down acetylcholine, the brain’s primary neurotransmitter for memory encoding and attention. When acetylcholinesterase is inhibited, acetylcholine persists longer in the synapse and keeps those memory-encoding circuits more active. This is, notably, the same mechanism exploited by several FDA-approved Alzheimer’s medications, including donepezil and rivastigmine.
Because of this shared mechanism, pinene has also been proposed as an anti-THC molecule. THC impairs short-term memory partly by suppressing acetylcholine release in the hippocampus, so a compound that preserves acetylcholine levels could, in theory, offset that effect. It’s a compelling hypothesis — and one that the cannabis industry has leaned into, with some producers marketing high-pinene strains as cognitively “cleaner” options.
What a human trial actually found
Here’s where the story gets more complicated. In 2025, researchers at Johns Hopkins University published results from a completed clinical trial that directly tested whether alpha-pinene could mitigate THC-induced cognitive impairment in healthy human adults. The trial, registered as NCT04130633 and published in Medical Cannabis and Cannabinoids, administered 30 mg of inhaled THC alongside varying doses of alpha-pinene — including doses at and above what is naturally found in cannabis flower.
The result was not what the hypothesis predicted. Co-administration of alpha-pinene with THC did not reduce memory impairment or meaningfully alter any of the cognitive or physiological effects of THC. The researchers noted this finding was inconsistent with some cannabis industry claims and with speculation by some cannabis researchers.
That’s an important data point. It doesn’t invalidate the preclinical work or the mechanistic rationale — acetylcholinesterase inhibition is a real pharmacological effect — but it does mean the leap from mechanism to clinically meaningful protection in humans isn’t supported by the best available evidence so far. The doses used in cannabis flower may simply be too low to produce the effect, or the interaction between inhaled terpenes and THC may be more complex than the theory allows.
Where does that leave alpha-pinene?
The honest answer is: the mechanism is real, the animal evidence is promising, but right now there is no human proof that alpha-pinene improves memory — in any context.
The Johns Hopkins trial didn’t just test the anti-THC claim. It also included a pinene-alone arm. In healthy adults, alpha-pinene administered on its own produced no significant cognitive effects compared to placebo. No improvement, no impairment — nothing measurable. That’s a meaningful null result, and it comes from a rigorous, double-blind, placebo-controlled design.
One detail worth noting: Ethan Russo, whose writing did much to popularise the modern entourage effect hypothesis and helped establish the theoretical case for pinene counteracting THC, was a co-author on this trial. His presence on a paper that doesn’t support his own earlier hypothesis says something about the integrity of the research — and about how seriously the cannabis science community is now taking the question of whether these effects are real in people, not just in petri dishes and rodent models.
Pinene is not alone in this. A similar pattern has played out with myrcene, where a widely repeated claim about its effects turned out to rest on far thinner evidence than its reputation suggested.
The Alzheimer’s angle remains active research territory, and the BDNF pathway findings from 2023 suggest there may be neuroprotective effects worth pursuing in disease contexts rather than healthy populations. A terpene that does nothing for a healthy adult’s memory might still matter for someone whose hippocampal circuits are already under stress. That’s a different and arguably more important question — and one that human trials haven’t yet answered.
For now, the science says: alpha-pinene is pharmacologically interesting, the smell of pine forests may be more than just pleasant — something we explore in pinene and the medicinal molecules of the forest — but if you’re choosing a cannabis strain on the basis that it will protect your memory, you’re ahead of the evidence.
Sources
- Allenspach M, Steuer C. α-Pinene: A never-ending story. Phytochemistry. 2021.
- Lee G-Y, et al. Effects of α-pinene on scopolamine-induced memory impairment in mice. Evidence-Based Complementary and Alternative Medicine. 2017.
- Perry NSL, Houghton PJ, Theobald A, Jenner P, Perry EK. In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. Journal of Pharmacy and Pharmacology. 2000;52(7):895–902. doi:10.1211/0022357001774598
- McPartland JM, Russo EB. Cannabis and cannabis extracts: greater than the sum of their parts? Journal of Cannabis Therapeutics. 2001.
- Hashemi P, Ahmadi S. Alpha-pinene moderates memory impairment induced by kainic acid via improving the BDNF/TrkB/CREB signaling pathway in rat hippocampus. Frontiers in Molecular Neuroscience. 2023. doi:10.3389/fnmol.2023.1202232
- Kumar L, Spindle TR, Zamarripa CA, Elder HJ, Russo EB, Bigelow G, Vandrey R. The individual and interactive effects of alpha-pinene and delta-9-tetrahydrocannabinol in healthy adults. Medical Cannabis and Cannabinoids. 2025;8(1):144–157. doi:10.1159/000547014
Originally published November 2022. Updated July 2026 to correct the trial citation, clarify the origin of the entourage-effect hypothesis, and add links to our wider terpene coverage.
Research for this article was identified and reviewed using DeepWeed, T&T’s cannabis research database. Explore the underlying studies and evidence summaries there.
